TY - JOUR
T1 - Four-dimensional Multiphase Steady-State MRI with Ferumoxytol Enhancement
T2 - Early Multicenter Feasibility in Pediatric Congenital Heart Disease
AU - Nguyen, Kim Lien
AU - Ghosh, Reena M.
AU - Griffin, Lindsay M.
AU - Yoshida, Takegawa
AU - Bedayat, Arash
AU - Rigsby, Cynthia K.
AU - Fogel, Mark A.
AU - Whitehead, Kevin K.
AU - Hu, Peng
AU - Finn, J. Paul
N1 - Funding Information:
Supported by the National Heart, Lung, and Blood Institute (grant R01HL127153). K.L.N. supported by American Heart Association grant 18TPA34170049, VA-MERIT grant I01-CX001901, and National Institutes of Health grant R01HL148182. R.M.G. supported by National Institutes of Health grant T32GM008562. L.M.G. supported by American Heart Association grant 19TPA34850066. C.K.R. supported by National Institutes of Health grant R01HL115828 and American Heart Association grant 19TPA34850066. M.A.F. supported by National Institutes of Health grants R01HL149139 and R01HL142142. P.H. supported by National Institutes of Health grants R01HL127153 and R01HL148182, VA-MERIT grant I01-CX001901, and American Heart Association grant 18TPA34170049. J.P.F. supported by National Institutes of Health grants R01HL127153 and R01HL148182 and American Heart Association grant 18TPA34170049.
Publisher Copyright:
© RSNA, 2021
PY - 2021/7
Y1 - 2021/7
N2 - Background: The value of MRI in pediatric congenital heart disease (CHD) is well recognized; however, the requirement for expert oversight impedes its widespread use. Four-dimensional (4D) multiphase steady-state imaging with contrast enhancement (MUSIC) is a cardiovascular MRI technique that uses ferumoxytol and captures all anatomic features dynamically. Purpose: To evaluate multicenter feasibility of 4D MUSIC MRI in pediatric CHD. Materials and Methods: In this prospective study, participants with CHD underwent 4D MUSIC MRI at 3.0 T or 1.5 T between 2014 and 2020. From a pool of 460 total studies, an equal number of MRI studies from three sites (n = 60) was chosen for detailed analysis. With use of a five-point scale, the feasibility of 4D MUSIC was scored on the basis of artifacts, image quality, and diagnostic confidence for intracardiac and vascular connections (n = 780). Respiratory motion suppression was assessed by using the signal intensity profile. Bias between 4D MUSIC and two-dimensional (2D) cine imaging was evaluated by using Bland-Altman analysis; 4D MUSIC examination duration was compared with that of the local standard for CHD. Results: A total of 206 participants with CHD underwent MRI at 3.0 T, and 254 participants underwent MRI at 1.5 T. Of the 60 MRI examinations chosen for analysis (20 per site; median participant age, 14.4 months [interquartile range, 2.3–49 months]; 33 female participants), 56 (93%) had good or excellent image quality scores across a spectrum of disease complexity (mean score ± standard deviation: 4.3 ± 0.6 for site 1, 4.9 ± 0.3 for site 2, and 4.6 ± 0.7 for site 3; P < .001). Artifact scores were inversely related to image quality (r = -0.88, P < .001) and respiratory motion suppression (P < .001, r = -0.45). Diagnostic confidence was high or definite in 730 of 780 (94%) intracardiac and vascular connections. The correlation between 4D MUSIC and 2D cine ventricular volumes and ejection fraction was high (range of r = 0.72–0.85; P < .001 for all). Compared with local standard MRI, 4D MUSIC reduced the image acquisition time (44 minutes ± 20 vs 12 minutes ± 3, respectively; P < .001). Conclusion: Four-dimensional multiphase steady-state imaging with contrast enhancement MRI in pediatric congenital heart disease was feasible in a multicenter setting, shortened the examination time, and simplified the acquisition protocol, independently of disease complexity.
AB - Background: The value of MRI in pediatric congenital heart disease (CHD) is well recognized; however, the requirement for expert oversight impedes its widespread use. Four-dimensional (4D) multiphase steady-state imaging with contrast enhancement (MUSIC) is a cardiovascular MRI technique that uses ferumoxytol and captures all anatomic features dynamically. Purpose: To evaluate multicenter feasibility of 4D MUSIC MRI in pediatric CHD. Materials and Methods: In this prospective study, participants with CHD underwent 4D MUSIC MRI at 3.0 T or 1.5 T between 2014 and 2020. From a pool of 460 total studies, an equal number of MRI studies from three sites (n = 60) was chosen for detailed analysis. With use of a five-point scale, the feasibility of 4D MUSIC was scored on the basis of artifacts, image quality, and diagnostic confidence for intracardiac and vascular connections (n = 780). Respiratory motion suppression was assessed by using the signal intensity profile. Bias between 4D MUSIC and two-dimensional (2D) cine imaging was evaluated by using Bland-Altman analysis; 4D MUSIC examination duration was compared with that of the local standard for CHD. Results: A total of 206 participants with CHD underwent MRI at 3.0 T, and 254 participants underwent MRI at 1.5 T. Of the 60 MRI examinations chosen for analysis (20 per site; median participant age, 14.4 months [interquartile range, 2.3–49 months]; 33 female participants), 56 (93%) had good or excellent image quality scores across a spectrum of disease complexity (mean score ± standard deviation: 4.3 ± 0.6 for site 1, 4.9 ± 0.3 for site 2, and 4.6 ± 0.7 for site 3; P < .001). Artifact scores were inversely related to image quality (r = -0.88, P < .001) and respiratory motion suppression (P < .001, r = -0.45). Diagnostic confidence was high or definite in 730 of 780 (94%) intracardiac and vascular connections. The correlation between 4D MUSIC and 2D cine ventricular volumes and ejection fraction was high (range of r = 0.72–0.85; P < .001 for all). Compared with local standard MRI, 4D MUSIC reduced the image acquisition time (44 minutes ± 20 vs 12 minutes ± 3, respectively; P < .001). Conclusion: Four-dimensional multiphase steady-state imaging with contrast enhancement MRI in pediatric congenital heart disease was feasible in a multicenter setting, shortened the examination time, and simplified the acquisition protocol, independently of disease complexity.
UR - http://www.scopus.com/inward/record.url?scp=85109115912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109115912&partnerID=8YFLogxK
U2 - 10.1148/radiol.2021203696
DO - 10.1148/radiol.2021203696
M3 - Article
C2 - 33876971
AN - SCOPUS:85109115912
VL - 300
SP - 162
EP - 173
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 1
ER -